162 related articles for article (PubMed ID: 33045891)
1. Dexmedetomidine inhibits microglial activation through SNHG14/HMGB1 pathway in spinal cord ischemia-reperfusion injury mice.
Ta Na HS; An M; Zhang T; Deni W; Hou L; Jin K
Int J Neurosci; 2022 Jan; 132(1):77-88. PubMed ID: 33045891
[TBL] [Abstract][Full Text] [Related]
2. The Pathway of Let-7a-1/2-3p and HMGB1 Mediated Dexmedetomidine Inhibiting Microglia Activation in Spinal Cord Ischemia-Reperfusion Injury Mice.
Ha Sen Ta Na ; Nuo M; Meng QT; Xia ZY
J Mol Neurosci; 2019 Sep; 69(1):106-114. PubMed ID: 31190218
[TBL] [Abstract][Full Text] [Related]
3. SYVN1 attenuates ferroptosis and alleviates spinal cord ischemia-reperfusion injury in rats by regulating the HMGB1/NRF2/HO-1 axis.
Guo L; Zhang D; Ren X; Liu D
Int Immunopharmacol; 2023 Oct; 123():110802. PubMed ID: 37591122
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J
Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
[TBL] [Abstract][Full Text] [Related]
6. Interference with long noncoding RNA SNHG3 alleviates cerebral ischemia-reperfusion injury by inhibiting microglial activation.
Huang D; Cao Y; Zu T; Ju J
J Leukoc Biol; 2022 Apr; 111(4):759-769. PubMed ID: 34411323
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling.
Zhao L; Zhai M; Yang X; Guo H; Cao Y; Wang D; Li P; Liu C
J Cell Mol Med; 2019 Dec; 23(12):8173-8183. PubMed ID: 31625681
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA SNHG14 Promotes Ischemic Brain Injury via Regulating miR-199b/AQP4 Axis.
Zhang G; Li T; Chang X; Xing J
Neurochem Res; 2021 May; 46(5):1280-1290. PubMed ID: 33609254
[TBL] [Abstract][Full Text] [Related]
9. [Dexmedetomidine alleviates hepatic ischemia-reperfusion injury by regulating MALAT1/miR-126-5p/HMGB1 axis].
Ma XG; Liu Y; Xue MX
Sheng Li Xue Bao; 2021 Apr; 73(2):253-262. PubMed ID: 33903887
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH
PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD : The Role of Dexmedetomidine in AD.
Tan Q; Liu L; Wang S; Wang Q; Sun Y
Neurotox Res; 2023 Oct; 41(5):471-480. PubMed ID: 37656385
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG14 promotes OGD/R-induced neuron injury by inducing excessive mitophagy via miR-182-5p/BINP3 axis in HT22 mouse hippocampal neuronal cells.
Deng Z; Ou H; Ren F; Guan Y; Huan Y; Cai H; Sun B
Biol Res; 2020 Sep; 53(1):38. PubMed ID: 32912324
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury.
Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F
PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
Sun Z; Zhao T; Lv S; Gao Y; Masters J; Weng H
J Transl Med; 2018 Jul; 16(1):209. PubMed ID: 30031397
[TBL] [Abstract][Full Text] [Related]
15. Propofol Protects against Cerebral Ischemia/Reperfusion Injury by Down-Regulating Long Noncoding RNA SNHG14.
Sun B; Ou H; Ren F; Guan Y; Huan Y; Cai H
ACS Chem Neurosci; 2021 Aug; 12(16):3002-3014. PubMed ID: 34369750
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of lncRNA FIRRE relieved the neuropathic pain of female mice by suppressing HMGB1 expression.
Wen Y; Fan X; Bu H; Ma L; Kong C; Huang C; Xu Y
Mol Cell Biochem; 2021 Feb; 476(2):841-852. PubMed ID: 33151463
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine protects hepatic cells against oxygen-glucose deprivation/reperfusion injury via lncRNA CCAT1.
Zhou Z; Chen Q; Wan L; Zheng D; Li Z; Wu Z
Cell Biol Int; 2018 Sep; 42(9):1250-1258. PubMed ID: 29851220
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine postconditioning alleviates spinal cord ischemia-reperfusion injury in rats via inhibiting neutrophil infiltration, microglia activation, reactive gliosis and CXCL13/CXCR5 axis activation.
Chen F; Wang D; Jiang Y; Ma H; Li X; Wang H
Int J Neurosci; 2023 Jan; 133(1):1-12. PubMed ID: 33499703
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine inhibits inflammatory response and oxidative stress through regulating miR-205-5p by targeting HMGB1 in cerebral ischemic/reperfusion.
Yang JJ; Zhao YH; Yin KW; Zhang XQ; Liu J
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):478-486. PubMed ID: 34196265
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
Chen Y; Huang Y; Xiong B; Luo H; Song X
Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
